Evolution of Vesicoureteral Reflux in Patients With Myelomeningocele in a Proactive Follow-Up Protocol

O E Blain1, J Ruiz1, C Sager1

  • 1Department of Urology, Hospital "Prof. Dr. Juan P. Garrahan", Pichincha 1890, C1245 CABA, Buenos Aires, Argentina.

PubMed
Abstract

Insights

The incidence of vesicoureteral reflux (VUR) in myelomeningocele (MMC) patients is 16%. A proactive approach led to a 65% VUR resolution rate within two years, though most patients still develop chronic kidney disease (CKD).

Area of Science:

  • Pediatric Urology
  • Nephrology
  • Developmental Biology

Background:

  • Myelomeningocele (MMC) is associated with a significant incidence of vesicoureteral reflux (VUR), ranging from 17% to 26.3% in the first six months of life.
  • A proactive management strategy for VUR in MMC patients has shown potential for resolution rates between 30% and 50% over 2-3 years.

Purpose of the Study:

  • To determine the incidence of VUR in pediatric patients with MMC.
  • To identify factors associated with VUR occurrence in this population.
  • To analyze the progression of VUR and chronic kidney disease (CKD) under a proactive management protocol.

Main Methods:

  • Retrospective observational cohort study (Level of Evidence: III) of newborns with MMC managed proactively between 2015 and 2020.
  • Patients were categorized based on the presence or absence of VUR identified via videourodynamic study (VUDS) at a mean age of 6 months.
  • Demographic and nephro-urological variables were compared between initial diagnosis and the last follow-up year.

Main Results:

  • The overall incidence of VUR in pediatric MMC patients was 16% (14 out of 68 analyzed).
  • Low-grade VUR was predominant (78.6%), with a VUR resolution rate of 64.3% within a median of 22 months.
  • Surgical closure of the MMC defect after the first 24 hours of life was significantly associated with VUR (p < 0.001); 57% of patients developed CKD.

Conclusions:

  • The incidence of VUR in pediatric MMC patients is 16%, with a high resolution rate (65% within 2 years) observed under a proactive management protocol.
  • Despite VUR resolution, the majority of these patients are at high risk for developing chronic kidney disease (CKD).
  • Early surgical intervention timing may influence VUR development in MMC patients.

Related Concept Videos

Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
23
Urinary Tract Calculi VI: Surgical Management01:25

Urinary Tract Calculi VI: Surgical Management

Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
26
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
40
Urodynamic Studies: Uroflowmetry01:19

Urodynamic Studies: Uroflowmetry

Uroflowmetry is a non-invasive urodynamic test designed to measure various aspects of urination, including volume, flow rate, and the time to void. This test is crucial for diagnosing and assessing conditions such as bladder outlet obstruction, bladder dysfunction, incomplete bladder emptying, incontinence, and urinary tract blockages caused by benign prostatic hyperplasia (BPH) and urethral strictures.Pre-Test Instructions:Before a uroflowmetry test, patients are typically advised to drink...
553
Imaging Studies VI: Voiding Cystourethrography and Cystography01:22

Imaging Studies VI: Voiding Cystourethrography and Cystography

Voiding Cystourethrography (VCUG) and Cystography are specialized radiographic procedures used to examine the structure and function of the bladder and urethra.Voiding Cystourethrography (VCUG)A Voiding Cystourethrogram (VCUG) is a diagnostic imaging procedure that assesses the anatomy and function of the lower urinary tract. It focuses on the bladder, bladder neck, and urethra, helping detect abnormalities such as vesicoureteral reflux (VUR)—the backward or reverse flow of urine into the...
116
Ureters01:22

Ureters

The ureters are retroperitoneal tubes located on either side of the vertebral column. They are responsible for transporting urine from each kidney to the urinary bladder. These tubes have thick walls and are approximately 25-30 cm long. Their diameter is around 10 mm at the renal pelvis, gradually narrowing to 1 mm as the ureter obliquely enters the posterior bladder wall through the ureteric orifices. The shape of these orifices is slit-like, which helps to prevent urine backflow toward the...
732